Silibinin

水飞蓟宾

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameSilibinin
Drug Alias Namesilibinine西利马灵西里马灵silibininumsilibinina +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Allergic asthmaSmoking Cessation +[18
Global Approved IndicationsDyspepsiaHepatitisFatty Liver +[4
Approved Indications in ChinaHepatitisFatty Liver
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryUnited StatesVietnamSerbia +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsDyspepsiaAtrial FibrillationParkinson Disease +[7
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Allergic asthmaSmoking Cessation +[11

Other Information

ATC CodeA05BA03